Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05560932 · ClinicalTrials.gov registry record · NA
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05560932 is a NA study that has completed, run by Yale University. The registered enrollment target is 50 participants.
The verdict
NCT05560932, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationale is that any alcohol use may interact with medications in serious ways leading to adverse outcomes, including bothersome symptoms.
Interventions
- BEHAVIORAL IMB-motivational interviewing (MI) techniques (IMB-MI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2024-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05560932
The ClinicalTrials.gov registry entry for NCT05560932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMB-motivational interviewing (MI) techniques (IMB-MI) is the first listed.
NCT05560932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05560932 about?
NCT05560932 is a clinical study titled "HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1". This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationa...
What is the current status of trial NCT05560932?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-03-06. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT05560932?
The interventions under investigation include: IMB-motivational interviewing (MI) techniques (IMB-MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05560932?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.